Glenmark receives ANDA approval for Brimonidine Tartrate and Timolol Maleate ophthalmic solution
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million